Literature DB >> 11703950

Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience).

M Singh1, P B Berger, H H Ting, C S Rihal, S H Wilson, R J Lennon, G S Reeder, J F Bresnahan, D R Holmes.   

Abstract

Earlier studies documented an increased risk of percutaneous coronary intervention (PCI) in patients with angiographic evidence of thrombus. With newer antiplatelet agents and stents, it is not known whether thrombus is a risk factor after PCI. This study examines whether outcome of PCI in patients with thrombus has improved, and whether thrombus is associated with adverse outcome after PCI in the current era. This single-institution retrospective analysis of PCI in 7,184 patients was divided into 2 periods: group I, 1990 to 1995 (n = 3,640), and group II, 1996 to 1999 (n = 3,544). The groups were subdivided according to the presence or absence of angiographic thrombus before PCI. We compared the outcome of PCI for patients with and without thrombus in group II. A comparison was made in the 2 groups in patients with angiographic thrombus. Procedural success improved in group II compared with group I patients with thrombus (93% vs 88%, p <0.001). There was significant reduction in abrupt closure in the recent era in patients with thrombus (4% vs 7%, p = 0.01). In group II, procedural success remained lower in patients with (93% vs 96%) than without thrombus (p <0.001). After adjusting for the significant univariate characteristics of group II patients, thrombus remained an independent predictor of Q-wave infarction (odds ratio 3.78; 95% confidence interval [CI], 1.8 to 8.0; p <0.0013) and the composite end point of death, Q-wave infarction, and emergency bypass surgery (odds ratio 2.37; 95% CI 1.4 to 4.1; p = 0.002). There was a trend toward increased in-hospital death among patients with thrombus (odds ratio 2.06; 95% CI 0.9 to 4.8; p = 0.09). The 1-year outcome after successful PCI was similar for those with and without thrombus. Despite improvement in the outcome of patients with thrombus undergoing PCI in recent years, thrombus is still an independent predictor of adverse in-hospital outcomes after PCI.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703950     DOI: 10.1016/s0002-9149(01)02040-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Thrombus aspiration in primary coronary intervention.

Authors:  Jen-Yu Wang; Chuan-Chieh Liu; Chih-Cheng Lai
Journal:  CMAJ       Date:  2010-10-18       Impact factor: 8.262

Review 2.  The management of thrombotic lesions in the cardiac catheterization laboratory.

Authors:  Fadi Matar; Jad Mroue
Journal:  J Cardiovasc Transl Res       Date:  2011-10-21       Impact factor: 4.132

3.  Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trials.

Authors:  Umesh U Tamhane; Stanley Chetcuti; Irfan Hameed; P Michael Grossman; Mauro Moscucci; Hitinder S Gurm
Journal:  BMC Cardiovasc Disord       Date:  2010-02-26       Impact factor: 2.298

4.  Impact of thin-cap fibroatheroma on predicting deteriorated coronary flow during interventional procedures in acute as well as stable coronary syndromes: insights from optical coherence tomography analysis.

Authors:  Tadatsugu Gamou; Kenji Sakata; Takao Matsubara; Toshihiko Yasuda; Kenji Miwa; Masaru Inoue; Honin Kanaya; Tetsuo Konno; Kenshi Hayashi; Masaaki Kawashiri; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2014-07-19       Impact factor: 2.037

5.  Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience.

Authors:  Mandeep Singh; Charanjit S Rihal; Bernard J Gersh; Veronique L Roger; Malcolm R Bell; Ryan J Lennon; Amir Lerman; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2008-06-17       Impact factor: 24.094

Review 6.  Coronary thrombus in patients undergoing primary PCI for STEMI: Prognostic significance and management.

Authors:  Sabine Vecchio; Elisabetta Varani; Tania Chechi; Marco Balducelli; Giuseppe Vecchi; Matteo Aquilina; Giulia Ricci Lucchi; Alessandro Dal Monte; Massimo Margheri
Journal:  World J Cardiol       Date:  2014-06-26

7.  Rationale and design of a prospective, observational study for the QUantitative EStimation of Thrombus burden in patients with ST-Elevation Myocardial Infarction using micro-computed tomography: the QUEST-STEMI trial.

Authors:  Efstratios Karagiannidis; Nikolaos V Konstantinidis; Georgios Sofidis; Evangelia Chatzinikolaou; Georgios Sianos
Journal:  BMC Cardiovasc Disord       Date:  2020-03-11       Impact factor: 2.298

Review 8.  Embolic protection devices in saphenous vein graft and native vessel percutaneous intervention: a review.

Authors:  Eron Sturm; David Goldberg; Sheldon Goldberg
Journal:  Curr Cardiol Rev       Date:  2012-08

Review 9.  Pathophysiology of coronary thrombus formation and adverse consequences of thrombus during PCI.

Authors:  Sundararajan Srikanth; John A Ambrose
Journal:  Curr Cardiol Rev       Date:  2012-08

10.  COVID-19 pandemic and STEMI: pathway activation and outcomes from the pan-London heart attack group.

Authors:  Callum D Little; Tushar Kotecha; Luciano Candilio; Richard J Jabbour; George B Collins; Asrar Ahmed; Michelle Connolly; Ritesh Kanyal; Ozan M Demir; Lucy O Lawson; Brian Wang; Sam Firoozi; James C Spratt; Divaka Perera; Philip MacCarthy; Miles Dalby; Ajay Jain; Simon J Wilson; Iqbal Malik; Roby Rakhit
Journal:  Open Heart       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.